Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07350148 · ClinicalTrials.gov registry record · NA

Opioid Adherence and Support Through Innovative Texting Strategies

A NA study of Chronic Pain and Opioid Use Disorder (OUD), sponsored by University of New Mexi.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT07350148: Recruiting NA study of Chronic Pain and Opioid Use Disorder (OUD), sponsored by University of New Mexi.

NCT07350148 is a NA study of Chronic Pain and Opioid Use Disorder (OUD) that is actively recruiting participants, run by University of New Mexi. The registered enrollment target is 60 participants, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07350148, a NA study of Chronic Pain and Opioid Use Disorder (OUD), is actively recruiting participants, sponsored by University of New Mexi.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

The goal of this clinical trial is to examine the effects of reminder and mindfulness text messages on medication adherence and managing craving, pain, and withdrawal symptoms in people taking medications for opioid use disorder through assessment questions collected twice daily during the course of treatment. The main questions it aims to answer are: 1. Do daily medication reminder text messages increase medication adherence for people taking medications for opioid use disorder? 2. To what extent do people engage with the daily mindfulness messages? 3. What impact does daily mindfulness text message quantity have on craving, pain, forgetfulness, and withdrawal symptoms? Participants will: 1. Receive daily medication reminder text messages for at least 24 weeks (i.e., 6 months) 2. Receive up to 6 mindfulness messages per day for 4 weeks (i.e., 1 month) 3. Answer daily questions twice a day during the 4 weeks of mindfulness messages 4. Answer questions about the study when enrolling, at the end of the 4 weeks of mindfulness messages, and at 4 and 16 weeks after the end of the mindfulness messages

Primary Outcome

Participants reply to a binary ("Today, did you think about or use any suggestion from the OASIS Study text messages?") and continuous ("How much did you think about or use any suggestion from the OASIS text messages?; response range: 0=not at all, 10=very much) question about intervention engagement. They also indicate how much they believe the texting helped them manage their pain, urge to use opioids, remember to take their medication, and manage their withdrawal symptoms (response range: 0=n

Interventions

  • BEHAVIORAL Mindfulness text messages

Study Locations (1)

New Mexico

  • University of New Mexico - Albuquerque

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2025-10-13
Est. Completion 2029-03
Phase NA
University of New Mexi

76 total trials

What NCT07350148 shows while recruiting

NCT07350148 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (92% lower).

The record links to 2 conditions, with Chronic Pain appearing as the primary indexed condition, and to 1 intervention - of which Mindfulness text messages is the first listed.

NCT07350148 reports a single indexed study location in New Mexico.

Frequently Asked Questions

What is clinical trial NCT07350148 about?

NCT07350148 is a clinical study titled "Opioid Adherence and Support Through Innovative Texting Strategies". The goal of this clinical trial is to examine the effects of reminder and mindfulness text messages on medication adherence and managing craving, pain, and withdrawal symptoms in people taking medications for opioid use disorder through assessment questions collected twice daily during the course of...

What is the current status of trial NCT07350148?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2025-10-13. Estimated completion is 2029-03.

What conditions does trial NCT07350148 study?

This clinical trial studies the following conditions: Chronic Pain, Opioid Use Disorder (OUD).

What interventions are being tested in trial NCT07350148?

The interventions under investigation include: Mindfulness text messages (BEHAVIORAL).

Who is sponsoring clinical trial NCT07350148?

This trial is sponsored by University of New Mexi, which has 76 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07350148 being conducted?

This trial has 1 study location across New Mexico. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07350148's enrollment target sits among peer trials

60 176th of 301 higher than 112 of 301 other Chronic Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Chronic Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07350148, the US trial registry maintained by the National Library of Medicine. NCT07350148 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.